方正证券：“人工智能+”驱动医疗产业革命 AI医疗进入百花盛开时刻

Group 1 - The core viewpoint of the article highlights the revolutionary development of the medical industry driven by "Artificial Intelligence+" with accelerated application of high-end innovative devices such as brain-computer interfaces (BCI) and surgical robots [1] Group 2 - The commercialization of non-invasive brain-computer interfaces is rapidly advancing, driven by stringent domestic regulatory approvals and the large rehabilitation patient population, indicating a broad market outlook [1] - Breakthroughs have been achieved in invasive brain-computer interfaces, with the first clinical trial expected to be conducted successfully by 2025 [1] - Domestic companies are accelerating self-research and collaborative layouts in the BCI sector, while the medical insurance payment system is continuously improving to support market expansion [1] Group 3 - The rapid development of artificial intelligence has led to the integration and upgrade of surgical robots with AI and 5G remote technologies [1] - The demand for surgical robots is increasing due to factors such as aging population and uneven distribution of medical resources, with the surgical robot market in China expected to exceed 70 billion yuan by 2030 [1]